About
Portfolio
News
Contact
About
Portfolio
News
Contact
All News
FDA Grants Fast Track Status to Aegle Therapeutics’ AGLE-102 for the Treatment of Dystrophic Epidermolysis Bullosa
Oct 01, 2020
Aegle Therapeutics Completes $6.5M Series A Financing
Sep 29, 2020
Latest Penn biotech spinout taking on cancer raises $1.6M from investors
Mar 31, 2020
Zai Lab Appoints Lonnie Moulder to Board of Directors
Jan 14, 2020
Helsinn appoints Eric Cornut and Lonnie Moulder to the Board of Directors
Jan 13, 2020
Aegle Therapeutics Announces $4M Financing to Fund Groundbreaking Stem Cell Exosome Clinical Trial to Treat Orphan Disease Dystrophic Epidermolysis Bullosa
Jan 07, 2020
